
Medpace Holdings MEDP
€ 369.31
0.69%
Quartalsbericht 2026-Q1
hinzugefügt 23.04.2026
Medpace Holdings EV 2011-2026 | MEDP
EV Jährlich Medpace Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 B | 10.8 B | 11.9 B | 7.96 B | 6.61 B | 5.04 B | 3.44 B | 2.63 B | 1.89 B | 1.56 B | 553 M | 695 M | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 14 B | 553 M | 5.59 B |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 17.65 | 3.67 % | $ 176 M | ||
|
Agilent Technologies
A
|
45.8 B | $ 119.12 | 1.34 % | $ 36.2 B | ||
|
Myriad Genetics
MYGN
|
598 M | $ 4.1 | -18.59 % | $ 380 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
NeoGenomics
NEO
|
1.85 B | $ 8.7 | -1.81 % | $ 1.11 B | ||
|
National Research Corporation
NRC
|
432 M | $ 18.33 | -2.19 % | $ 410 M | ||
|
Natera
NTRA
|
5.53 B | $ 215.43 | 4.19 % | $ 21.2 B | ||
|
Koninklijke Philips N.V.
PHG
|
13.2 B | $ 27.15 | 2.65 % | $ 20 B | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Personalis
PSNL
|
229 M | $ 6.04 | 8.54 % | $ 358 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Soleno Therapeutics
SLNO
|
2.13 B | $ 52.93 | 0.01 % | $ 2.69 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 20.85 | 0.7 % | $ 1.11 B | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Thermo Fisher Scientific
TMO
|
186 B | $ 475.86 | 1.96 % | $ 179 B | ||
|
Trinity Biotech plc
TRIB
|
133 M | $ 0.61 | 1.13 % | $ 61.9 M | ||
|
Co-Diagnostics
CODX
|
-1.92 M | $ 1.61 | 1.26 % | $ 2.14 M | ||
|
Castle Biosciences
CSTL
|
665 M | $ 24.82 | 0.89 % | $ 689 M | ||
|
Twist Bioscience Corporation
TWST
|
1.55 B | $ 60.05 | 5.91 % | $ 3.59 B | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 186.57 | 0.64 % | $ 9.25 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Waters Corporation
WAT
|
21.6 B | $ 351.47 | 2.54 % | $ 20.9 B | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 15.15 | 1.68 % | $ 458 M | ||
|
Guardant Health
GH
|
15.2 B | $ 91.39 | 2.09 % | $ 11.5 B | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 124.91 | 2.96 % | $ 10.3 B | ||
|
Illumina
ILMN
|
15.3 B | $ 141.73 | 1.91 % | $ 22.5 B | ||
|
Senseonics Holdings
SENS
|
376 M | $ 5.11 | 2.2 % | $ 213 M | ||
|
Interpace Biosciences
IDXG
|
16.3 M | $ 2.01 | 0.1 % | $ 8.89 M | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.14 | -2.06 % | $ 4.92 M | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 87.0 | 1.37 % | $ 5.87 B | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 259.67 | 0.98 % | $ 21.6 B | ||
|
Celcuity
CELC
|
5.57 B | $ 142.15 | 0.32 % | $ 6.65 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 9.28 | 0.11 % | $ 2.01 B | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 191.61 | 0.4 % | $ 21.3 B |